Institutional investors purchased a net $228.4 thousand shares of IRWD during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 107.40% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ADAGE CAPITAL MANAGEMENT LP Bought 3.5 Million shares of Ironwood Pharmaceuticals ...
T. ROWE PRICE ASSOCIATES, INC. Bought 1.3 Million shares of Ironwood Pharmaceuticals ...